IL17A and myeloid sarcoma: Multiple Sclerosis (MS) is an autoimmune disease characterized by autoreactive interferon gamma (IFN-γ) and interleukin (IL)-17 producing T cell-mediated inflammation, followed by neural cell demyelination [1].